News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Alliances (World)
MACROGEN And Silicon Biosystems Menarini To Co-Develop CLIA-Certified Genomic Cancer Assays 2/12/2016
Protein Sciences Corporation And UNIGEN Reach Agreement to Source Flublok Influenza Vaccine from Japan 2/12/2016
Microlin Bio Signs Exclusive License And Research Agreement With Universite Laval To Develop microRNA-Based Treatments For Alzheimer’s Disease 2/11/2016
Jiangsu Hengrui Medicine Co. Ltd. Uses Partnerships To Advance Novel Drug Programs 2/10/2016
Six Big Shot Life Science Companies Ban Together with TransCelerate BioPharma to Launch BioCelerate 2/10/2016
Lonza And Renova Therapeutics Announce Manufacturing Agreement For Clinical Supply Of RT-100 Gene Therapy 2/10/2016
STAAR Surgical (STAA) And Memira Holding Announce Cooperation Agreement For Memira's Eye Clinics Throughout Scandinavia 2/9/2016
Microsoft, Novartis AG (NVS) Partner Up to Fight Multiple Sclerosis with Video Game 2/9/2016
Immunovia Announces Collaboration With Mount Sinai Health System To Validate Early Detection Blood Test For Pancreatic Cancer 2/9/2016
Fraunhofer ITEM Takes Over And Continues Development Of Inhalation Technology Assets From Takeda (TKPYY) 2/9/2016
ICON Selected By Genomics England To Support The Largest Genome Sequencing Project Of Its Kind For Cancer And Rare Diseases 2/9/2016
Volpi Group Partners With QIAGEN N.V. (QGEN) To Manufacture The Imaging Module For The GeneReader[TM] NGS Platform 2/8/2016
Nuvo Research (NRI.TO) And Horizon Pharma (HZNP) Extend Term Of Manufacturing Agreement 2/8/2016
RedHill Biopharma Ltd. (RDHL) Announces Collaboration with Germany’s Fraunhofer Institute For Oncology Drug RP101 2/8/2016
MedinCell Enters Into A Technology Agreement For Long-Acting Injectable Products 2/4/2016
Takeda (TKPYY) Wagers $1 Billion+ More on Mersana Therapeutics' Antibody Program 2/4/2016
Evonik Industries Enters Into Research Partnership With Institute Of Chemical Technology, Mumbai For Research & Development 2/3/2016
GlaxoSmithKline (GSK) Bets Another $500 Million on Adaptimmune (ADAP)'s Clinical Cancer Program 2/3/2016
Royal Philips Electronics N.V. (PHG) Teams Up With Validic To Integrate Personal Health Data From Third-Party Devices And Apps Into Connected Health Services 2/3/2016
New Agreements Underscore QIAGEN N.V. (QGEN)'s Leadership In Bioinformatics 2/3/2016
As Sanofi (SNY) Restructures, Merck & Co. (MRK) Joint Vaccines Venture Might End 2/2/2016
DNX Biopharmaceuticals And XL-Protein Enter Into A Shareholder Agreement To Develop And Commercialize Novel Long Acting Biopharmaceuticals. 2/2/2016
VolitionRX Initiates Prostate Cancer Study In Collaboration With The Surrey Cancer Research Institute, University of Surrey, UK 2/2/2016
PharmaMar S.A. And Specialised Therapeutics Asia Sign Licensing And Marketing Agreement For APLIDIN (plitidepsin) Covering Several Asian Countries 2/2/2016
Heptares Launches "Orbit" Initiative - A New Collaborative Drug R&D Programme For Industry And Academia Focused On G Protein-Coupled Receptors (GPCRS) 2/2/2016
Plandai Biotechnology, Inc. (PLPL.OB) Announces New Product With Coyne Healthcare 2/2/2016
Teva (TEVA) And AbCellera Biologics Enter Into Agreement To Discover Rare Monoclonal Antibodies 2/2/2016
Eisai Company (ESALY.PK) Buys Cancer Drug Rights From HUYA Bioscience in $280 Million+ Deal 2/1/2016
Braeburn Pharma And Knight Therapeutics Announce Canadian Sublicense Agreement For PROBUPHINE 2/1/2016
Mauna Kea Technologies Announces Expanded Strategic Multiyear Partnership With Fujifilm China 2/1/2016
ImageIQ And InvitroCue Forge Partnership To Advance Quantitative Image Analysis For Preclinical Researchers In Asia 2/1/2016
Mymetics Announces Discontinuation of the RSV Collaborative Project 1/29/2016
Full Genomes Corporation Collaborates With Novogene To Offer Low-Cost Whole Genome Ancestry Test 1/28/2016
ALK-Abello A/S And Abbott (ABT) Expand Partnership Into South-East Asian Growth Markets 1/28/2016
EIB Lends EUR 20m To TRANSGENE (ENX:TNG) 1/28/2016
XTL Biopharma (XTLB) Joins Corporate Advisory Council Of The Lupus Foundation Of America 1/27/2016
Google (GOOG), Royal Philips Electronics N.V. (PHG) and IBM (IBM) are Hooking Up with NHS 1/26/2016
Pharma Giants AstraZeneca PLC (AZN), GlaxoSmithKline (GSK) and Johnson & Johnson (JNJ) Partner Up with UK Universities to Create $57 Million R&D Fund 1/25/2016
Affimed Therapeutics AG (AFMD) Enters Into Collaboration With Merck & Co. (MRK) To Evaluate AFM13 In Combination With KEYTRUDA (Pembrolizumab) For Patients With Hodgkin Lymphoma 1/25/2016
GlaxoSmithKline (GSK) Kills U.S. Part of Eczema Treatment Deal With Basilea (BSLN.SW) 1/22/2016
Capital Pro-Égaux Inc. (NEX: CPE.H) Announces The Conclusion Of A License Agreement With MIS Implants Technologies, Ltd. 1/22/2016
GlaxoSmithKline (GSK) in Talks to Form $1 Billion Medtech Joint Venture with Qualcomm 1/21/2016
Neovacs Sets Up Joint Venture with Stellar Biotech, New Site Will Hire 50 to 100 Staffers by Midterm 1/21/2016
Protagen AG Joins RA-MAP Consortium To Support Identification Of Predictors Of Remission In Rheumatoid Arthritis (RA) 1/21/2016
Philogen S.p.A. Announces Exercise Of Options Within The License Agreement With Pfizer (PFE) For The Development And Potential Commercialization Of Multiple Antibody Drug Conjugates (ADCs) And Targeted Technologies 1/21/2016
MediWound (MDWD) Expands Latin American Distribution Of NexoBrid Through Agreement With Avalon Pharmaceuticals (AVRX) 1/21/2016
Upsher-Smith Laboratories And Sanion Sign Collaboration Agreement For Development Of Novel Therapeutics For Neurological Disorders 1/20/2016
The Medicines Patent Pool Signs First Sub-Licences For Hepatitis C Medicine Daclatasvir 1/20/2016
IRX Therapeutics And ImmunID Announce Collaboration To Predict Response To IRX-2 Cancer Immunotherapy Using ImmunTraCkeR 1/19/2016
Ceva And Zoion Pharma Announce Collaboration To Develop Epithelial Sodium Channel Blockers To Treat Veterinary Ocular Surface Diseases 1/19/2016
Anatara Lifesciences Announces Exclusive Research Evaluation And License Option Agreement With Zoetis (ZTS) 1/18/2016
IXICO Awarded Four Contracts Worth A Combined Value Of Over £3.0 Million 1/18/2016
Xbrane Signs Deal With Helvetic Biopharma For Its Lead Ranibizumab Biosimilar, Xlucane 1/15/2016
Takeda (TKPYY) Scouting for Deals with Apple (AAPL), Google (GOOG) and More in Quest to Become a Digital Leader by 2025 1/13/2016
BioMed X - Merck & Co. (MRK) Collaboration In The Field Of Selective Kinase Inhibitors Reaches Major Milestone 1/13/2016
XTL Biopharmaceuticals Ltd. (XTLB) Advances Formulation Of Its hCDR1 Drug For Clinical Trials In The Treatment Of Lupus Through Use Of Cydex Pharmaceuticals' Captisol 1/13/2016
Catalent (CTLT) Bags a $618 Million SMARTag Technology Pact with Drug Giant Roche (RHHBY) 1/13/2016
Arena (ARNA) Scores a $262 Million Schizophrenia Deal with Boehringer Ingelheim 1/13/2016
NeuroVive (NVP) Enters Strategic Collaboration With University of Pennsylvania 1/12/2016
CrystalGenomics Partners With TR-Pharm For Acelex Commercialization In Turkey And MENA 1/12/2016
BioLineRx Ltd. Announces Collaboration With MSD To Investigate The Combination Of KEYTRUDA (pembrolizumab) And BL-8040 In Pancreatic Cancer 1/12/2016
BioNTech Announces Update In Immuno-oncology Collaboration With Genmab, Inc. (GEN.CO) 1/12/2016
QIAGEN N.V. (QGEN) Reaches Milestone With Portfolio Of Master Collaboration Agreements For Pharma Companion Diagnostics 1/12/2016
Oxford Instruments And Zurich Instruments Announce A Technical Collaboration For Low Temperature Physics 1/12/2016
SALVAT And Lee's Pharmaceutical (HK) Limited Announce Exclusive License And Supply Agreement For Duoxal In Greater China 1/12/2016
Sanofi (SNY) Deepens Cancer Push by Deals with MA Startup Warp Drive Bio and Innate Pharma (IPH.PA ) Worth $1.2 Billion 1/11/2016
Sorrento And Karolinska Institutet Establish Exclusive Partnership For Research And Development Of Natural Killer Cell-Based Therapies 1/11/2016
f-Star Enters Into Collaborative Discovery & Development Agreement With AbbVie (ABBV) For Bispecific Antibodies In Immuno-Oncology 1/11/2016
OWC Pharmaceutical Research Announces $750K Equity Purchase Agreement With Kodiak Capital Group 1/11/2016
LifeWatch AG Signs Agreement With AliveCor 1/11/2016
China's Nuance Biotech Options Two Cancer Treatments From Celleron 1/11/2016
Debiopharm International SA And Arbor Pharmaceuticals Announce Their US Commercialization Partnership For Triptorelin In Central Precocious Puberty 1/11/2016
Innate Pharma (IPH.PA ) In-Licenses Orega Biotech's First-In-Class Anti-Cd39 Checkpoint Inhibitor Program 1/11/2016
Advinus Therapeutics (P) Ltd., A TATA Enterprise, Meets Milestone In Drug Discovery Alliance 1/11/2016
Tiny Surface Oncology Gets $170 Million Upfront in Next-Gen Cancer Deal with Novartis AG (NVS) 1/11/2016
Johnson & Johnson (JNJ) In-Licenses Immune Adjuvant From Sino Biopharmaceuticals Ltd. (SBMFF) 1/8/2016
Akashi, Grunenthal Knock Out a $100 Million DMD Pact 1/8/2016
Mylan (MYL), Momenta (MNTA) Ink $245 Million Deal to Develop and Commercialize Six Biosimilar Products 1/8/2016
Clasado And University of Oxford Demonstrate That Consuming A Unique Carbohydrate Complex During Early Life Could Provide Benefits For Brain Health That Extend Into Adulthood 1/8/2016
Evotec AG (EVTG.F) And UCB, Inc. (UCBJF.PK) Sign Multi-Year Sample Management Agreement 1/7/2016
Kymab And MD Anderson Cancer Center Announce Strategic Partnership In Immuno-Oncology Research & Development 1/7/2016
Enterome Announces Collaboration With Johnson & Johnson Innovation (JNJ) Focused On The Discovery Of Novel Targets And Therapeutics For Crohn's Disease 1/7/2016
EndoChoice Enters Distribution Agreement With Chindex Medical Limited For China 1/7/2016
ViiV Healthcare To Progress Collaboration With Janssen To Develop The First Long-Acting, Two Drug Injectable Regimen For Treatment Of HIV-1 Infection 1/7/2016
Apogenix Receives First Milestone Payment From CANbridge Licensing Agreement And Signs Amendment To Include Taiwan 1/7/2016
BoneSupport Announces CERAMENT Focused Research Collaboration With Rigshospitalet, Copenhagen University Hospital 1/7/2016
Teva (TEVA) And Checkpoint Announce License Agreement For Oral PARP Inhibitor 1/7/2016
Swedish Orphan Biovitrum Gains Commercial Rights For Relistor, Deflux And Solesta From Pharmaswiss 1/7/2016
Jubilant Biosys And Sanofi Deutschland Gmbh Enter Into A Strategic Alliance Focusing On Metabolic Disorders Therapeutic Area 1/7/2016
Merck & Co. (MRK) Strikes $280 Million Cancer Discovery Deal with Complix 1/6/2016
Medicure Inc. (MCU) Announces ANDA Collaboration With Apicore 1/6/2016
Cell Therapy Catapult, University of Birmingham And Cancer Research Technology Launch New Collaboration For CAR-T Cell Immuno-Oncology Therapy Development 1/6/2016
Voisin Consulting Life Sciences And IQone Healthcare Form Partnership For Commercialization Services In Switzerland 1/6/2016
Rosetta Genomics Ltd. (ROSG) Grants Sublicenses To Mirna For MicroRNA-Related Patents For The Development Of Oncology Therapeutics 1/6/2016
Bristol-Myers Squibb (BMY), Oncodesign SA Knock Out a $83 Million+ Drug Discovery Pact 1/5/2016
Rhythm And Camurus Announce License Agreement For Extended Release Fluidcrystal Setmelanotide 1/5/2016
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Chong Kun Dang For BRINAVESS In South Korea 1/5/2016
Annapurna Therapeutics To Collaborate With Weill Cornell Medicine On Gene-Therapy Portfolio 1/5/2016
Baxalta (BXLT) to Fork Over Up to $1.6 Billion for Symphogen Products 1/4/2016
Merus And Gustave Roussy Form Strategic Collaboration To Develop Innovative Bispecific Antibodies For Therapeutic Immuno-Oncology Applications 1/4/2016
Merck KGaA (MKGAF.PK), Darmstadt, Germany, Pfizer (PFE) And Syndax Announce Collaboration To Evaluate Combination Of Avelumab And Entinostat In Ovarian Cancer 1/4/2016
Zhangjiajie (China) Jinchi Giant Salamander Biological Technology Co. Ltd & Zhangjiajie Tourism Group Co. Ltd Entered A Strategic Cooperation Agreement 1/4/2016
Jazz Pharmaceuticals (JAZZ) Partnering 2010-2015 12/31/2015
FUJIFILM And Anicom Holdings, Inc. Enter Into Partnership To Establish A Joint Venture For Developing And Providing Cutting-Edge Veterinary Technologies And Services With Focus On Regenerative Medicine 12/30/2015
Oramed (ORMP) Announces Closing Of Licensing And Investment Deal With HTIT For Oral Insulin Capsule In China 12/29/2015
Sihuan Pharmaceutical And Japan's RaQualia To Collaborate On Analgesic Drugs 12/29/2015
Karolinska Development AB And Karolinska Institutet Holding AB Sign A New Non-Exclusive Deal Flow Agreement To Improve The Translation Of Medical Innovations Into Successful Commercial Enterprises 12/22/2015
BASF And Sumitomo Chemical Company, Ltd. Explore In Vitro System For Chemical Safety Evaluation 12/21/2015
Pharming And Hyupjin Announce Receipt Of The South Korean Marketing Authorization For RUCONEST 12/21/2015
Easton Pharmaceuticals (OP: EAPH) Of Chengdu Partners With Germany's XL-protein 12/21/2015
Recipharm AB Signs Manufacturing Agreement With Alcon (ACL) And Acquires Facility In France, Adding New Niche Capabilities 12/21/2015
Gilead (GILD) Invests Up to $2 Billion in Galapagos (GLPG.BR)’ Anti-inflammatory Drug 12/18/2015
Bavarian Nordic (BAVA.CO), Janssen Pharmaceutical Strike $171 Million HPV Vaccine Pact 12/18/2015
The Medicines Patent Pool And AbbVie (ABBV) Sign Licensing Agreement To Increase Access To Crucial HIV Treatments Throughout Africa 12/18/2015
SYGNIS Significantly Expands Its Asian Distribution Network By Signing Three Additional Agreements With PhileKorea And Pharma Tech Korea As Well As Axil Scientific For Singapore 12/17/2015
Sinclair IS Pharma Plc Completes £132 Million Strategic Disposal Of Non-Aesthetics Business To Alliance Pharma Plc 12/17/2015
Emirates Gastroenterology & Hepatology Society And Vifor Pharma Collaborate To Advance Iron Deficiency (ID) Management In UAE 12/17/2015
TWi Biotechnology Inc. Announces Development And Commercialization Agreement And Collaboration With Castle Creek Pharmaceuticals, LLC 12/17/2015
XL-Protein And Easton Pharmaceuticals (OP: EAPH) Sign License Agreement To Develop Biopharmaceuticals Using Pasylation Technology 12/17/2015
Recipharm AB And LIDDS Signs Contract For Production Of Liproca Depot And Investment In LIDDS 12/16/2015
Tiny Startup Arsia Bags $100 Million+ Hemophilia Deal with Biogen (BIIB) 12/16/2015
Sanofi (SNY) Looks to Shake Things Up via $25 Billion Asset Swap with Boehringer Ingelheim 12/16/2015
AstraZeneca PLC (AZN) Pouring $800 Million into China R&D, Deepens Ties with WuXi AppTec 12/16/2015
WuXi PharmaTech (WX) And AstraZeneca PLC (AZN) Form Strategic Alliance To Expedite Development Of Astrazeneca's Innovative Biologics Portfolio In China 12/16/2015
Alimera Sciences (ALIM) Signs Agreement To Distribute ILUVIEN In The Middle East 12/15/2015
Neovacs SA Signs A Strategic Partnering Agreement With The Korean Company CKD Pharmaceutical Corp. 12/15/2015
Cambridge's Akebia (AKBA) Grabs an Asian Partner and Funding for Anemia Pill in $350 Million Deal 12/14/2015
Rosetta Genomics Ltd. (ROSG) And Biocept, Inc. (BIOC) Advance Collaboration To Proof-Of-Concept Studies Aimed At Microrna Profiling Of Circulating Tumor Cells To Enhance Lung Cancer Diagnosis 12/14/2015
Yisheng Biopharma And The United States Army Medical Research Institute Of Infectious Diseases Announce Collaboration On New Vaccine Against Ebola Virus 12/14/2015
Endo International (ENDP) Announces Extension Of U.S. Rights For Voltaren Gel 12/14/2015
Complix NV Advances Novel Biospecific Immunotherapeutic CMX-02 - Enters Agreement With Selexis SA To Access SUREtechnology Platform 12/14/2015
Novogene And Illumina (ILMN) To Co-Develop NGS Diagnostic System For Reproductive Health And Oncology Applications 12/14/2015
Mauna Kea Technologies And Cook Medical Enter Into A Global Multi-Year Commercialization Partnership For Endomicroscopy In Urology 12/11/2015
Bellicum (BLCM) And Astellas (ALPMY) Announce License Agreement For Cancer Target PSCA In Cell And Gene Therapy 12/11/2015
Prima Biomed (PRR.AX) Progresses Japanese Collaboration 12/11/2015
BIOSAFE And Stemlife Sign A Long Term Supply Agreement 12/10/2015
Novo Nordisk A/S (NVO), IBM (IBM) Join Forces to Create a Virtual Doctor 12/10/2015
SoCal Biotech BioAtla Forges a $1 Billion Antibody Partnership with Pfizer (PFE) 12/9/2015
Rhizen Pharmaceuticals S.A. Announces Exclusive Worldwide License Agreement For The Development And Commercialization Of A Dual PI3K-Delta Gamma Inhibitor 12/9/2015
AGTC (AGTC) And Synpromics Announce R&D Collaboration To Develop Synthetic Promoters For Enhanced Gene Therapy Candidates 12/9/2015
Hutchison China MediTech (Chi-Med) Relelase: US$105 Million Shanghai Land Compensation Agreement 12/9/2015
c-LEcta Expands Framework Supply Agreement 12/9/2015
Desktop Genetics Receives Strategic Investment From Illumina (ILMN) To Advance Genome Editing Software Platform 12/9/2015
WuXi PharmaTech (WX) And PRA Health Sciences Restructure Relationship In China 12/8/2015
Takeda (TKPYY) And Cour Partner To Develop Novel Therapies For Celiac Disease And Other Gastrointestinal Diseases 12/8/2015
Medicines360 Announces New Partnership With Marie Stopes International To Expand Access To Its Hormonal IUD To Women In Kenya, East Africa 12/7/2015
Frontline BioVentures To Form Strategic Partnership With Sinopharm Group (“Sinopharm”) 12/4/2015
FIND And Cepheid (CPHD) Announce A Strategic Collaboration To Advance Point-Of-Care TB Diagnosis 12/3/2015
bluebird bio (BLUE), ViroMed Forge $49 Million+ Pact to Develop CAR T-Cell Therapies 12/3/2015
Roaring Zymeworks Inks Antibody Pact Worth $440 Million+ with GlaxoSmithKline (GSK) 12/3/2015
Novo Nordisk A/S (NVO) Breathes New Life into XOMA  (XOMA) with $295 Million Diabetes Pact 12/2/2015
BioQ And Lunatus Execute Agreement To Commercialize Two Infusion Pharmaceuticals In Saudi Arabia, The United Arab Emirates, Qatar And Kuwait 12/2/2015
Summit Therapeutics Announces First Milestone Achieved In Strategic Alliance With University of Oxford For Future Generation Utrophin Modulators For Treatment Of DMD 12/2/2015
APR Applied Pharma Research S.A. And Eris Pharmaceuticals (Australia) Pty Ltd. Announce The Signature Of A License Agreement For The Distribution And Marketing Of The HALYKOO Line In Australia And New Zealand 12/2/2015
Starpharma Release: Second DEP Candidate Selected By AstraZeneca PLC (AZN) 12/2/2015
SYGNIS Signs Distribution Agreement With Mayflower Bioscience For The U.S. Market 12/2/2015
Roche (RHHBY) Pulls Plug on High-Profile $485.3 Million Superbug Antibiotic Project 12/1/2015
The Medicines Patent Pool (MPP) Signs A Collaborative Agreement With The University of Liverpool To Develop HIV Nanomedicines 12/1/2015
MR Solutions Ltd. Partners With Summit Pharmaceuticals International Corporation To Bring Preclinical Imaging To Japan 12/1/2015
Protagen AG Joins MATURA Consortium To Support Identification Of Treatment Response Predictors In Rheumatoid Arthritis (RA) 12/1/2015
RightEye Selects SMI Eye Trackers To Use In Eye Tracking-Based Vision Tests 12/1/2015
3SBio Inc. (SSRX) Acquires Control Of CP Guojian In $213 Million Deal 12/1/2015
Biovica And The International Breast Cancer Study Group & Breast International Group In Collaboration To Improve Outcome For Women With Breast Cancer 12/1/2015
Pfizer (PFE) Inks $1.89 Billion Discovery Deal with Heptares, Takes $33 Million Stake in Sosei 11/30/2015
Heptares Enters Strategic Drug Discovery Collaboration With Pfizer (PFE) Focused On GPCR Targets Across Multiple Therapeutic Areas 11/30/2015
BioLight Announces Partnership With Axella Research For CellDetect Non-Invasive Test For Monitoring Recurrence Of Bladder Cancer 11/30/2015
Accutest And Fox Chase Cancer Center - Temple Health Form Strategic Partnership On Clinical Trials For Oncology 11/30/2015
HUYA Bioscience International Announces A Strategic Alliance With The Korea Drug Development Fund 11/30/2015
Varian Medical Systems (VAR) And Apollo Group Sign Educational Partnership To Develop Radiotherapy Caregivers In India 11/30/2015
Sectra (SECTB) Continues Its Success In Breast Imaging IT - Provides Solution To Kentucky Breast Care 11/30/2015
Oramed (ORMP) Signs Up To $50 Million Licensing And Investment Agreements For Oral Insulin Capsule In China 11/30/2015
Cell Therapy Catapult Signs Memorandum Of Understanding With Kanagawa Prefecture, Japan 11/30/2015
Teva (TEVA) And Takeda (TKPYY) Establish Unique Partnership To Meet The Wide-Ranging Needs Of Patients And Growing Importance Of Generic Medicines Use In Japan 11/30/2015
Heptares Lines Up a $410 Million Migraine Pact with Teva (TEVA) 11/25/2015
Allergan (AGN) And Rugen Therapeutics Announce Collaboration To Discover And Develop Ground-Breaking Medicines To Treat Autism Spectrum Disorders And Obsessive-Compulsive Disorders 11/25/2015
BioLight Announces Joint Investment In Ioptima Subsidiary 11/25/2015
Ablynx (ABLYF), Novo Nordisk A/S (NVO) Ink Nanobody Pact Worth $399 Million+ 11/25/2015
TSO3 And Getinge Infection Control Sign Exclusive Global Distribution Agreement 11/25/2015
ACRES And Ethical GmbH, Switzerland To Collaborate On eAdjudication 11/25/2015
AstraZeneca PLC (AZN) Unafraid it May Have Given Sanofi (SNY) a Potential Blockbuster in Drug Swap 11/24/2015
LSP And Bristol-Myers Squibb (BMY) Enter Into Strategic Collaboration For Life Sciences Innovation In Europe 11/24/2015
EDELRIS Announce Exclusive License Agreement With Enyo Pharma 11/24/2015
US-Based Enova Illumination And Finland-Based Novocam Medical Innovations Start Joint Venture 11/24/2015
Debiotech And ARTORG Initiate An Exclusive Collaboration On The Next Generation Artificial Pancreas 11/24/2015
Uni-Bio Science Acquires Global Rights To Type 2 Diabetes Drug Mitiglinide From Jiangsu Hansoh Pharmaceutical Co. Ltd 11/24/2015
Idera Pharma (IDRA) Forges Renal Deal Worth $100 Million+ Deal with GlaxoSmithKline (GSK) 11/23/2015
Generon (Shanghai) Corporation Ltd. Collaborating With Mayo Clinic To Initiate A Phase IIa Study With F-652, A First-In-Class Biologic, To Treat Patients With Alcoholic Hepatitis 11/23/2015
Mobelife, A Materialise Company, Announces Collaboration With Exactech Australia 11/23/2015
Addex Therapeutics (ADXN.SW) And CHUV-UNIL Collaborators Awarded Swiss Grant To Advance Addex MGluR7 And MGluR4 Allosteric Modulators For Neurodegenerative And Psychiatric Diseases 11/23/2015
AstraZeneca PLC (AZN), Sanofi (SNY) to Exchange 210,000 Chemical Compounds 11/20/2015
ObsEva And Kissei Pharmaceutical Co., Ltd. Announce Global Agreement To Develop And Commercialize KLH-2109 For The Treatment Of Endometriosis 11/20/2015
ProMetic Life Sciences Inc. (PFSCF.PK) Enters Into Strategic Agreements With Prothera Biologics To Develop Plasma-Derived Inter-Alpha Inhibitor Proteins ("IAIP") For Orphan Diseases 11/19/2015
Teva (TEVA) And University College London Embark On Unique Brain Imaging Study Aimed At Unlocking A New Approach In Neurodegenerative Disease 11/19/2015
Ipsen (IPN.PA) And Interprotein Enter Into A Research Collaboration For Novel Peptides In Endocrinology 11/19/2015
Threshold Pharma (THLD) Extends $550 Million Deal with Merck KGaA (MKGAF.PK) for 50% of Cancer Drug’s U.S. Sales 11/18/2015
Genentech (RHHBY) Partners Up with Novartis AG (NVS) on Ex-U.S. Rights to Wet AMD Candidate Fovista 11/17/2015
Vigilant Biosciences Announces Distribution Agreements For OncAlert Oral Cancer System For Czech Republic And Slovakia, Israel And Baltic Region 11/17/2015
Morphotek Inc. Announces Collaboration Agreement With University of Gothenburg To Develop Farletuzumab, An Investigational Anti-Folate Receptor Alpha Monoclonal Antibody, For Alpha-Particle Radioimmunotherapy In Ovarian Cancer 11/17/2015
Summit Therapeutics And The University of Oxford Announce Multi-Year Extension Of Strategic Alliance For Development Of Utrophin Modulators For DMD 11/17/2015
2016 Royalties from Valeant (VRX) Deal About Half the Amount of 2015, Says MEDA 11/16/2015